Comprehensive Product Portfolio Capturing Global Market Share
Boasting a robust product portfolio, RAYSHAPE effectively meets diverse demands across various sectors. The company has independently developed over 20 high-performance photosensitive resins and end-use products, distinguished by their high reliability, precision, cost-effectiveness, and user-friendliness. These advantages have enabled RAYSHAPE to rapidly secure a significant share of the global dental 3D printing market. As chairside applications mature, further digital diagnostic and treatment scenarios are emerging. The company continues to leverage its integrated "3D printing equipment + AI-powered software" capabilities to deliver full-chain value, expanding from hardware and materials to software and services.
Explosive Overseas Growth with an Ecosystem Spanning 70+ Countries
RAYSHAPE has prioritized international expansion since its founding, building a global customer ecosystem through intensive, multi-channel brand presence and digital marketing strategies. Its overseas operations now extend to over 70 countries across Europe, North Africa, Asia-Pacific, North America, and Latin America. The company has partnered with more than 100 renowned international dental firms, including Kulzer, detax, bego, and DMG, validating its products in high-value applications like permanent crowns, removable dentures, and surgical guides. These partnerships provide reliable support to dental clinics and laboratories worldwide. The company projects a 120% year-over-year increase in international sales for 2025.
Furthermore, RAYSHAPE has completed mutual compatibility certifications with leading global dental material and equipment brands such as Keystone, Saremco, dreve, and dentona. These achievements confirm that the precision, stability, and open architecture of RAYSHAPE's systems fully comply with the rigorous clinical standards of Western markets. This positions the company to unlock new international distribution channels through co-marketing and cross-brand solutions, thereby amplifying its global influence and fostering a more extensive collaborative ecosystem.
Lean Manufacturing Center Inaugurated, Boosting Production Capacity
In July of this year, RAYSHAPE's new Lean Manufacturing Center commenced operations in the Changshu Economic and Technological Development Zone. With a total investment of RMB 50 million and a facility exceeding 10,000 square meters, the center will house new projects for R&D and production of dental medical materials and 3D printers. It is projected to achieve an annual output of 500 tons of dental materials and 10,000 3D printers, supporting the company's goal of reaching RMB 500 million in sales revenue within three years. The center's launch signifies a deeper commitment to digital dental 3D printing and is set to significantly enhance production efficiency and product quality, delivering greater value to dental clinics and labs.
High-Growth Trajectory Earns Continued Investor Confidence
Xingqi Fund under Falcon Investment (Co-Lead Investor): "3D printing is reshaping production models and clinical workflows in the dental industry, aligning perfectly with its digital transformation. The technology is rapidly gaining global penetration in dentistry, evolving from an auxiliary tool to a core solution for end-use treatments. This fundamental shift is elevating the entire industry's value and market potential. We have strong confidence in the RAYSHAPE team's sustained dedication and focus. Through global strategic positioning and innovative product applications, they have achieved rapid growth, establishing themselves as a frontrunner in this segment."
United Capital Investment (Co-Lead Investor): "Dentistry is a vital and high-potential application for 3D printing. The technology has become integral to digital oral healthcare, significantly accelerating the digital transformation of clinics and labs by integrating steps from scanning and CAD design to printing. RAYSHAPE has the potential to become a segment leader, leveraging superior products and meticulous operational expertise, showcasing the prowess of intelligent manufacturing from China in digital dentistry. Since our initial investment, their product launch cycle has accelerated markedly, and overseas growth has been robust. Our continued investment in this round will help RAYSHAPE accelerate its development and deepen its strategic footprint in dental 3D printing."
Chen Ge, Executive Director of Index Capital (Exclusive Financial Advisor): "Dentistry is at the forefront of the med-tech digital transformation. 3D printing, as a hardware platform with strong potential for commercial viability, is restructuring the dental supply chain and introducing a new paradigm of efficient, personalized, intelligent manufacturing to global oral care. In the era of AI-driven innovation, 3D printing is poised to become a primary commercial outlet for 'AI + Dentistry'. RAYSHAPE has adeptly capitalized on this trend, demonstrating sharp strategic insight and execution. They have successfully expanded applications from labs to the chairside, pushing digital solutions into the clinical core. The firm is steadfastly executing its global strategy, building partnership networks in key markets to create a virtuous cycle of international growth. Founder Mr. Liu possesses clear vision, strategic resolve, and exceptional leadership, having built a comprehensive organizational framework spanning technology, product, market, and global expansion. We believe under his guidance, RAYSHAPE will continue to set new benchmarks for dental 3D printing and has the potential to become a global leader in oral healthcare digital transformation."
Image by nanjixiong 